Reduction in serum pepsinogen I after Roux-en-Y gastric bypass

Journal of Gastrointestinal Surgery

Volumn 7, Issue 4, 2003, Pages 529-535

  Sundbom, Magnus ^a   Mårdh, Erik ^b   Mårdh, Sven ^b   Öhrvall, Margareta ^a   Gustavsson, Sven ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Dept of Surgery and Biomedicine ^*  (Sweden)

Author keywords

Gastric bypass; Gastritis; H. pylori; Morbid obesity; Pepsinogen

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; PEPSINOGEN I;

ADULT; ANTIBODY TITER; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; MORBID OBESITY; OBSERVATION; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; STATISTICAL SIGNIFICANCE; STOMACH BYPASS;

EID: 0038638306     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(03)00063-5     Document Type: Article

References (27)

1. Sugerman H.J., Kellum J.M., Engle K.M., Wolfe L., Starkey J.V., Birkenhauer R., Fletcher P., Sawyer M.J. Gastric bypass for treating severe obesity. Am J Clin Nutr. 55:(Suppl 2):1992;560S-566S.
2. Cowan C.G. Jr., Buffington C.K. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 22:1998;987-992.
3. McCarthy H.B., Rucker R.D. Jr., Chan E.K., Rupp W.M., Snover D., Goodale R.L., Buchwald H. Gastritis after gastric bypass surgery. Surgery. 98:1985;68-71.
4. Flickinger E.G., Sinar D.R., Pories W.J., Sloss R.R., Park H.K., Gibson J.H. The bypassed stomach. Am J Surg. 149:1985;151-156.
5. Printen K.J., LeFavre J., Alden J. Bleeding from the bypassed stomach after gastric bypass. Surg Gynecol Obstet. 156:1983;65-66.
6. Macgregor A.M., Pickens N.E., Thoburn E.K. Perforated peptic ulcer following gastric bypass for obesity. Am Surg. 65:1999;222-225.
7. Raijman I., Strother S.V., Donegan W.L. Gastric cancer after gastric bypass for obesity. J Clin Gastroenterol. 13:1991;191-194.
8. Lord R.V., Edwards P.D., Coleman M.J. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 67:1997;580-582.
9. Mårdh E., Mårdh S., Mårdh B., Borch K. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta. 320:2002;17-27.
10. Oksanen A., Sipponen P., Karttunen R., Miettinen A., Veijola L., Sarna S., Rautelin H. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut. 46:2000;460-463.
11. Ley C., Mohar A., Guarner J., Herrera-Goepfert R., Figuroa L.S., Halperin D., Parsonnet J. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Markers Prev. 10:2001;107-112.
12. Korstanje A., den Hartog G., Biemond I., Lamers C.B. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol. 236:(Suppl):2002;22-26.
13. Gritti I., Banfi G., Roi G.S. Pepsinogens: Physiology, pharmacology, pathophysiology and exercise. Pharmacol Res. 41:2000;265-281.
14. Samloff I.M., Varis K., Ihamaki T., Siurala M., Rotter J.I. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 83:1982;204-209.
15. Ohkusa T., Takashimizu I., Fujiki K., Araki A., Honda K., Shimoi K., Sakurazawa T., Horiuchi T., Suzuki S., Ariake K., Ischii K. Changes in serum pepsinogen, gastrin, and immunoglobulimn G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection. J Clin Gastroenterol. 25:1997;317-322.
16. Samloff I.M., Stermmermann G.N., Heilbrun K., Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology. 90:1986;570-576.
17. Lindgren A., Burman P., Kilander A.F., Nilsson O., Lindstedt G. Serum antibodies to H+,K+-ATPase, serum pepsinogen A and Helicobacter pylori in relation to gastric mucosa morphology in patients with low or low-normal concentrations of serum cobalamins. Eur J Gastroenterol Hepatol. 10:1998;583-588.
18. Matsukura N., Onda M., Tokunaga A., Fujita I., Okuda T., Mizutani T., Kyono S., Yamashita K. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer. J Clin Gastroenterol. 17:(Suppl 1):1993;S146-S150.
19. Kodoi A., Yoshihara M., Sumii K., Haruma K., Kajiyama G. Serum pepsinogen in screening for gastric cancer. J Gastroenterol. 30:1995;452-460.
20. Yoshihara M., Sumii K., Haruma K., Kiyohira K., Hattori N., Kitadai Y., Komoto K., Tanaka S., Kajiyama G. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol. 93:1998;1090-1096.
21. Yoshihara M., Sumii K., Haruma K., Kiyohira K., Hattori N., Tanaka S., Kajiyama G., Shigenobu T. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Hiroshima J Med Sci. 46:1997;81-86.
22. Kitahara F., Kobayashi K., Sato T., Kojima Y., Araki T., Fujino M.A. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 44:1999;693-697.
23. Sepulveda A.R., Coelho L.G. Helicobacter pylori and gastric malignancies. Helicobacter. 7:(Suppl):2002;37-42.
24. Koskenpato J., Farkkila M., Sipponen P. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Scand J Gastroenterol. 37:2002;778-784.
25. Takahashi S. Long-term Helicobacter pylori infection and the development of atrophic gastritis and gastric cancer in Japan. J Gastroenterol. 37:(Suppl 13):2002;24-27.
26. Karlsson F.A., Burman P., Loof L., Mardh S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest. 81:1988;475-479.
27. Lundegardh G., Adami H.O., Helmick C., Zack M., Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 319:1988;195-200.